Lotus Eye Hospital P/E Ratio
Current P/E Ratio
1642.14
High Valuation
Very High - High growth expectations or significantly overvalued
Lotus Eye Hospital P/E ratio. Lotus Eye Hospital (LOTUSEYE) P/E ratio is 1642.14 (High), EPS (TTM) ₹0.04, current price ₹115.37 on NSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see LOTUSEYE stock price BSE.
Current Valuation Metrics
P/E Ratio
1642.14
Current Price
₹115.37
EPS (TTM)
₹0.04
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
66.44
Sector Median
43.09
Sector Rank
#11 of 57
Sector Percentile
19.3%
LOTUSEYE P/E Ratio — Valuation Signal & Historical Context
Lotus Eye Hospital P/E 1642.14 — signal: Overvalued. Check Lotus Eye Hospital marketcap in USD to track the company's total market size over time.
- Stock appears overvalued with PE of 1642.14, suggesting caution for new investments
- Trading at premium to sector average PE of 66.44
LOTUSEYE vs Healthcare Services Peers — P/E Ratio Comparison
Lotus Eye Hospital P/E 1642.14 vs Healthcare Services average 66.44, median 43.09 — range 6.97–596.0.
Sector Average
66.44
Sector Median
43.09
Lowest P/E
6.97
Highest P/E
596.0
Companies
57
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 6.97 | ₹131 | Low |
| Abate AS Industries | ABATEAS | 10.23 | ₹122 | Low |
| Deccan Health Care | DECCAN | 11.6 | ₹29 | Low |
| Nidan Labs & Healthcare | NIDAN | 11.94 | ₹17 | Low |
| One Global Service Provi… | ONEGLOBAL | 13.97 | ₹1,027 | Low |
| Shanmuga Hospital | SHANMUGA | 14.42 | ₹61 | Low |
| Indraprastha Medical Cor… | INDRAMEDCO | 16.52 | ₹3,061 | Moderate |
| Invicta Diagnostic | INVICTA | 17.24 | ₹85 | Moderate |
| Dhanvantri Jeevan Rekha | ZDHJERK | 18.19 | ₹9 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 18.62 | ₹1,793 | Moderate |